Business Context and Reporting Period
This Form 8-K Current Report for SeaStar Medical Holding Corporation covers events occurring on June 26, 2023, with the report filed on June 30, 2023. The Company is incorporated in Delaware and its common stock (trading symbol: ICU) and warrants (ICUCW) are listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not provide specific financial data such as revenue, profit, cash flow, margins, debt levels, or liquidity metrics for the reporting period.
Material Changes and Corporate Events
- Nasdaq Delisting Notice: On June 26, 2023, the Company received a deficiency letter from Nasdaq stating that its common stock closing bid price had been below the minimum $1.00 requirement for 30 consecutive business days. The Company has been granted an initial 180-day compliance period until December 26, 2023, to regain compliance.
- Stockholder Meeting Results: The annual meeting held on June 28, 2023, approved four key proposals:
- Election of two Class I Directors (Andres Lobo and Rick Barnett).
- Approval of the full issuance of shares issuable pursuant to Convertible Notes and Warrants to comply with Nasdaq Listing Rule 5635(d).
- Approval of the full issuance of shares issuable pursuant to the Company's Equity Line of Credit to comply with Nasdaq Listing Rule 5635(d).
- Ratification of Armanino LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
Guidance, Outlook, and Risks
Outlook and Management Commentary: Management intends to monitor the closing bid price of the Common Stock and may consider available options to regain compliance with the Nasdaq Bid Price Requirement before the December 26, 2023 deadline. The deficiency letter has no immediate effect on the Company's listing status.
Risks: The primary risk identified is the potential failure to regain compliance with the $1.00 minimum bid price requirement within the 180-day window, which could lead to delisting from The Nasdaq Capital Market.
Investor Verification Checklist
- Verify the current trading price of ICU to assess the likelihood of meeting the $1.00 bid price requirement by December 26, 2023.
- Review the Company's capital structure regarding the Convertible Notes, Warrants, and Equity Line of Credit approved by stockholders to understand potential dilution.
- Monitor future filings for updates on the Nasdaq compliance status or any reverse stock split proposals.
- Confirm the appointment of Armanino LLP as the auditor for the upcoming fiscal year.